AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model

Leukemia

Volumn 24, Issue 5, 2010, Pages 1018-1024

  Komeno, Y ^a   Kitaura, J ^a   Watanabe Okochi, N ^b   Kato, N ^a   Oki, T ^a   Nakahara, F ^a   Harada, Y ^c   Harada, H ^c   Shinkura, R ^d   Nagaoka, H ^d   Hayashi, Y ^e   Honjo, T ^d   Kitamura, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e Gumna Children S Medical Center   (Japan)

Author keywords

AID; B leukemia lymphoma; BMT; T lymphoma

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; K RAS PROTEIN; NOTCH1 RECEPTOR; PROTEIN EBF1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GRAFT RECIPIENT; LATENT PERIOD; MOUSE; MUTATIONAL ANALYSIS; MYELOID LEUKEMIA; NONHUMAN; NUDE MOUSE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC HYPERMUTATION; T CELL LYMPHOMA; THYMUS; TRANSGENIC MOUSE;

EID: 77952428846     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.40     Document Type: Article

References (31)

1. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18470-18476.
2. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553-563.
3. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, Imai K et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 2003; 4: 843-848.
4. Shinkura R, Ito S, Begum NA, Nagaoka H, Muramatsu M, Kinoshita K et al. Separate domains of AID are required for somatic hyper-mutation and class-switch recombination. Nat Immunol 2004; 5: 707-712.
5. Barreto V, Reina-San-Martin B, Ramiro AR, McBride KM, Nussenzweig MC. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 2003; 12: 501-508.
6. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341-346.
7. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574-3580.
8. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003; 63: 3894-3898.
9. Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009; 16: 232-245.
10. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008; 40: 108-112.
11. Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, Callen E et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med 2008; 205: 1949-1957.
12. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007; 13: 470-476.
13. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197: 1173-1181.
14. Morisawa T, Marusawa H, Ueda Y, Iwai A, Okazaki IM, Honjo T et al. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer 2008; 123: 2735-2740.
15. Rucci F, Cattaneo L, Marrella V, Sacco MG, Sobacchi C, Lucchini F et al. Tissue-specific sensitivity to AID expression in transgenic mouse models. Gene 2006; 377: 150-158.
16. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M et al. Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci USA 2006; 103: 2752-2757.
17. Casellas R, Yamane A, Kovalchuk AL, Potter M. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology 2009; 126: 316-328.
18. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063-1066.
19. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 1007-1014.
20. Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y et al. AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood 2008; 111: 4297-4308.
21. Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 1995; 14: 6209-6217.
22. Pasqualucci L, Migliazza A, Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003; 101: 2914-2923. (Pubitemid 36857975)
23. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110-114.
24. Longerich S, Tanaka A, Bozek G, Nicolae D, Storb U. The very 5 end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J Exp Med 2005; 202: 1443-1454.
25. Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol 2008; 3: 587-613.
26. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758-764.
27. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118: 431-438.
28. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M et al. Negative regulation of activation-induced cytidine deami-nase in B cells. Proc Natl Acad Sci USA 2006; 103: 2752-2757.
29. Liu M, Schatz DG. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol 2009; 30: 173-181.
30. Geisberger R, Rada C, Neuberger MS. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc Natl Acad Sci USA 2009; 106: 6736-6741.
31. O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813-1824.